November 2, 2022 — Several awards of distinction were presented at The VEINS (Venough Endovascular INinterventional Sstrategies) Conference 2022 October 30-31 in Las Vegas, NV. This comprehensive educational symposium focuses on the diagnosis, intervention and management of venous disorders. The conference, now in its 20th year, looks at PE, superficial and deep vein disease, pelvic vein disease, dialysis and medical management, allowing attendees to explore key clinical topics, current trends in practice and to get a glimpse of what’s next in venous veins. disease care.
Additionally, VIVA22, Oct. 31-Nov. 3, is a vascular education symposium that emphasizes innovation and multidisciplinary learning. The landmark conference marks VIVA’s 20th anniversary as a premier educational event for endovascular specialists. Planners note that VIVA22 continues to define innovation in vascular medicine and intervention, with a world-renowned multi-specialty faculty; concurrent sessions and extended pre-courses; state-of-the-art technology, according to conference planners.
The VIVA Foundation is a nonprofit organization committed to improving patient outcomes by advancing the field of vascular medicine and intervention through collaborative education, advocacy, and research. targeted.
VIVA and The VEINS bring together a multi-specialty global faculty to present a variety of lectures and live case presentations from clinical centers around the world. Attendees at both events include an audience of interventional cardiologists, interventional radiologists, vascular surgeons and specialists in endovascular medicine.
The live price
The recipient of the 2022 VIVA Foundation LIVE Award is Daniel Clair, MD, Vanderbilt University Medical Center, where he was recently appointed as the inaugural Chair and Professor of the Department of Vascular Surgery, specializing in innovative care for vascular disease.
The Lreader In EndoVascular Eeducation, the LIVE Award recognizes vascular specialists who have dedicated their professional careers to educating students, postgraduate trainees and peers in all aspects of vascular medicine and intervention. The presentation will take place on November 1 in Las Vegas, NV.
Clair is well known as an outstanding leader, serving on national, regional and local committees, including the Vascular Surgery Board of the American Board of Surgery and the Society of Vascular Surgery Education Council. He serves on the editorial boards of Vascular Disease Management and the Journal of Vascular Surgery and Endovascular Surgery.
Clair received her medical degree from the University of Virginia School of Medicine. He completed his surgical internship and residency, as well as a fellowship in vascular surgery, at Brigham & Women’s Hospital. He also completed a fellowship in clinical oncology with the American Cancer Society.
He served in the US Air Force as Chief of the Division of Vascular Surgery at Andrews Air Force Base before beginning his civilian practice at the Cleveland Clinic Foundation. He was appointed Division Chief of Vascular Surgery at New York Presbyterian Hospital/Presbyterian Campus, then returned to the Cleveland Clinic as Director of the Department of Vascular Surgery, a position he held for 10 years. Clair was then appointed professor and chair of the department of surgery at the University of South Carolina, where he completed a five-year term.
The VEINS Award
Vein Educator, Innovator and National Statesman Award – The VEINS Award recognizes individuals who have made significant contributions to improving care for patients with venous disease .
The 2022 VIVA Foundation VEINS Award recipient is Raghu Kolluri, MD, MS, who accepted the award at a ceremony on October 30.
In addition to his work as founder and co-course director of the VEINS conference, Kolluri is medical director of the Vascular Medicine system for OhioHealth System and Riverside Methodist Hospital, president of Syntropic CoreLab, clinical professor of medicine at the University from Ohio. Heritage College of Osteopathic Medicine and VIVA Board Member. He is the author of numerous articles and book chapters, and has lectured extensively on vascular disease. His research interests include DVT prophylaxis and vascular testing.
Other significant awards were presented Nov. 1, including the ATLAS Award and the Vascular Career Advancement Awards, recognizing achievement in key areas.
The ATLAS Prize
A Teacher, Leader and Scholar Award – The ATLAS Award celebrates the career and impact of physicians who have distinguished themselves as scholars and leaders in their respective vascular fields. They have dedicated their careers to advancing the care of patients with vascular disorders and have taught countless physicians techniques to expand care in the United States and around the world.
The VIVA Foundation has announced that its 2022 ATLAS Prize recipient is Michael Dake, MD.
Michael Dake, MD, is senior vice president of health sciences at Arizona University of Health Sciences, where he is a professor of medical imaging, surgery, and medicine. He is also Professor Emeritus of Cardiothoracic Surgery at Stanford University School of Medicine. At the University of Arizona, he is responsible for the medical schools in Tucson and Phoenix, as well as the schools of nursing, public health and pharmacy. He was Division Chief of Interventional Radiology for 15 years at Stanford before being named Chairman of the Department of Radiology at the University of Virginia. He returned to Stanford in 2008 to focus on developing endovascular procedures to manage patients with thoracic and abdominal diseases.
His research interests include the use of drug-eluting stents and balloons for the treatment of peripheral arterial disease (PAD) and the use of percutaneous therapies to treat a range of venous injuries. In addition to specialty certification in Diagnostic Radiology and Vascular and Interventional Radiology, Dr. Dake is board certified in Internal Medicine and Pulmonary Diseases.
The Vascular Career Advancement Award
VIVA and LINC have collaborated to develop the Vascular Career Advancement Award to recognize promising young physicians as potential leaders in the vascular field. Recipients are selected for their dedication to a multidisciplinary vascular care philosophy and to improving the care and outcomes of patients with vascular disease.
The recipients of the VIVA Foundation’s 2022 VCA Award are Eva Freisinger, MD, and Eric Secemsky, MD, MSc.
Eva Freisinger, MD, has been practicing at the University Hospital Münster since 2012 and became Senior Physician in the Department of Cardiology and Angiology in 2018. Her scientific interest lies in healthcare research for cardiovascular disease and medicine of the kind. She is currently a project manager in large projects funded by the German Federal Government.
Dr. Freisinger is the recipient of several awards and honors, most recently the August Wilhelm and Lieselotte Becht Scientific Prize from the German Heart Foundation in 2021 for his research on the safety of oral anticoagulation in high-risk individuals. Additionally, his large-scale, real-world analyzes of the safety of paclitaxel-coated devices in peripheral arteries have contributed significantly to reforming this methodical approach in PAD.
Eric A. Secemsky, MD, MSc, is director of vascular intervention at the CardioVascular Institute at Beth Israel Deaconess Medical Center, director of vascular research at the Smith Center for Outcomes Research in Cardiology, and assistant professor of medicine at Harvard Medical School.
Secemsky’s research focuses on the comparative effectiveness of coronary and vascular therapies, with an emphasis on the use of new statistical methods. It also examines outcomes related to cardiovascular disorders and the use of risk prediction models to guide treatment decisions. He is the author of over 100 peer-reviewed publications and has lectured nationally and internationally on his research. His research is funded by the NIH, Harvard Medical School, philanthropy, and extramural grants. He is also associate editor of Vascular Medicine and a member of the editorial board of Circulation: cardiovascular intervention.